Improvement of cardiac sympathetic innervation by renal transplantation

Journal of Nuclear Medicine

Volumn 45, Issue 7, 2004, Pages 1114-1120

  Kurata, Chinori ^a,b   Uehara, Akihiko ^a   Ishikawa, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yamaha Health Care Center   (Japan)

Author keywords

Autonomic nervous system; Heart rate variability; Kidney transplantation; Metaiodobenzylguanidine; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; METAIODOBENZYLGUANIDINE I 123; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DRUG UPTAKE; FEMALE; HEART NERVE; HEART RATE; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MEDIASTINUM; PRIORITY JOURNAL; SCINTIGRAPHY; SYMPATHETIC INNERVATION; UREMIA; AUTONOMIC NEUROPATHY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART ARRHYTHMIA; KIDNEY DISEASE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; ADULT; ARRHYTHMIA; AUTONOMIC NERVOUS SYSTEM DISEASES; CHILD; FEMALE; HEART RATE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 4043146511     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Zoccali C, Ciccarelli M, Mallamaci F, Maggiore Q. Parasympathetic function in haemodialysis patients. Nephron. 1986;44:351-354.
2. Kurata C, Wakabayashi Y, Shouda S, et al. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med. 1995;36:2037-2043.
3. 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol. 1996;3:508-515.
4. Steinberg AA, Mars RL, Goldman DS, Percy RF. Effect of end-stage renal disease on decreased heart rate variability. Am J Cardiol. 1998;82:1156-1158.
5. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH. Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol. 1999;10:1972-1981.
6. Vita G, Bellinghieri G, Trusso A, et al. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int. 1999;56:232-237.
7. Kurata C, Uehara A, Sugi T, et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron. 2000;84:312-319.
8. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
9. 123I]metaiodobenzylguanidine scintigraphy. Circulation. 1994;89:2843-2851.
10. van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation. 1997;95:1449-1454.
11. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98:1510-1516.
12. Zhang YH, Song YC, Zhu J, Hu TH, Wan LL. Effects of enalapril on heart rate variability in patients with congestive heart failure. Am J Cardiol. 1995;76:1045-1048.
13. Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol. 2000;36:1612-1618.
14. Korkmaz ME, Muderrisoglu H, Ulucam M, Ozin B. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol. 2000;86:649-653.
15. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med. 1997;38:1085-1089.
16. 123I-MIBG imaging. Jpn Heart J. 1998;39:743-751.
17. 123I-MIBG scintigraphic study. J Nucl Med. 2000;41:845-851.
18. 123I-metaiodobenzylguanidine uptake. J Nucl Med. 2001;42:49-54.
19. Strano S, De Castro S, Urani C, et al. Power spectrum analysis of heart rate variability following kidney transplantation. Transplant Proc. 1993;25:2600-2601.
20. Yildiz A, Sever MS, Demirel S, et al. Improvement of uremic autonomic dysfunction after renal transplantation: a heart rate variability study. Nephron. 1998;80:57-60.
21. Cashion AK, Hathaway DK, Milstead EJ, Reed L, Gaber AO. Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant. Transplantation. 1999;68:1846-1850.
22. 123I] metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine level. J Nucl Cardiol. 1997;4:515-523.
23. Röckel A, Hennemann H, Sternagel-Haase A, Heidland A. Uraemic sympathetic neuropathy after haemodialysis and transplantation. Eur J Clin Invest. 1979;9:23-27.
24. Agarwal A, Anand IS, Sakhuja V, Chugh KS. Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int. 1991;40:489-495.
25. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 1994;90:234-240.
26. Houle MS, Billman GE. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol. 1999;276:H215-H223.
27. Notarius CF, Butler GC, Ando S, Pollard MJ, Senn BL, Floras JS. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Clin Sci (Lond). 1999;96:557-565.
28. Kurata C. Uremic cardiac autonomic neuropathy. In: Bolis CL, Licinio J, Govoni S, eds. Handbook of the Autonomic Nervous System in Health and Disease. New York, NY: Marcel Dekker, Inc.; 2003:403-423.
29. Nakajo M, Shimabukuro K, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med. 1986;27:84-89.
30. 123I-mIBG in rats. Nucl Med Commun. 1988;9:663-667.
31. Dae MW, De Marco T, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: implications for clinical studies. J Nucl Med. 1992;33:1444-1450.
32. 123I-MIBG kinetics in rats. J Nucl Med. 1999;40:2088-2093.
33. Rabinovitch MA, Rose CP, Schwab AJ, et al. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med. 1993;34:589-600.
34. Rose CP, Cousineau D, Goresky CA, De Champlain J. Constitutive nonexocytotic norepinephrine release in sympathetic curves of in situ canine heart. Am J Physiol. 1994;266:H1386-H1394.
35. 123I-MIBG in long-distance runners. J Nucl Cardiol. 1997;4:396-402.
36. Converse RL Jr, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918.
37. 123I-MIBG in the failing human heart. J Nucl Med. 1999;40:224-231.
38. Tamura K, Tsuji H, Nishiue T, Yajima I, Higashi T, Iwasaka T. Determinants of heart rate variability in chronic hemodialysis patients. Am J Kidney Dis. 1998;31:602-606.
39. Roger SD, Baker LR, Raine AE. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO). Clin Nephrol. 1993;39:103-110.
40. Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974-1979.